an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial - Raal, F J; Santos, R D; Blom, D J (Lancet, 2010)
et al.